Hi! Twitter world. This is my 1st tweet presenting my 1st collection “Dr.K clinic” opensea.io/collection/drk… I try to connect world of NFT and dermatology. Also, the perspective of skin disease could be changed into the positive way, “skin artwork”. #openseaNFT #NFT #ThaiNFT

#2021GCAN Annual Research Symposium opens TODAY! Log in with your registrant password to hear our year in review lectures, a special lecture from Dr. Park of NIH and take a tour of this year’s posters. Not registered? Go to bit.ly/3FEOgMu.

Check out our population-based study on urate‐lowering therapy and hospital length of stay in gout patients! onlinelibrary.wiley.com/doi/10.1111/17…

#IRACON21 #IRACON2021 @2021Iracon IRA Indian Journal Of Rheumatology Excellent talk on Cutaneous Vasculitis 👉🏻 Skin - mirror of internal Disease 👉🏻 40-70% don't have an identifiable cause 👉🏻 Skin biopsy - gold std 👉🏻 Asses - chronicity, severity, systemic involvement

Differential diagnoses of ⛈️Thunderclap headache⚡ are indeed thunderous. Here is a brief 🧵. Aaron Berkowitz Casey Albin, MD Rabih Geha @DxRxEdu Zaven Sargsyan Ann Marie Kumfer Ravi Singh Gabriela F. Pucci, MD @jackpenner Travis Smith, D.O. FAAEM Sharmin Shekarchian The Clinical Problem Solvers #MedTwitter #NeuroTwitter #Neurology

⏫IgG4 🚫 IgG4 RD Elevated IgG4 levels can be seen: 👉 Chronic infections like #tuberculosis 👉Lymphoproliferative malignancies 👉 Bronchiectasis, #asthma 👉 Primary sclerosing cholangitis #RheumTwitter #MedTwitter #Rheumatology

Just released in The Journal of Rheumatology! Our paper is on gout flare during COVID-19 hospitalization. Very proud of our team: Satpanich P. Prof Rebecca Grainger Dr Philip Robinson 🇺🇦 jrheum.org/content/early/…

【Article Title】“Gout flare in the critical care setting: diagnostic challenges and treatment options” 【Click】signavitae.com/articles/10.22… #Gout; #Hospitalization; #Arthritis;#Criticalcare;#Uricacid;

Video Abstract Prevalence, risk factors, and outcomes of gout flare in patients hospitalized for PCR-confirmed COVID-19: A multicenter retrospective cohort study #gout #coronavirus Read the full article 📰 doi.org/10.3899/jrheum… Watch the video 📺 youtu.be/KVsYpGSuHNU

Excited to be part of the APLAR conference. APLAR Thanks to all collaborators. #APLAR22

Scleroderma therapeutics: we’re actually getting some choices! Christian Dejaco #EULAR2023 Dr. John Cush

Doctor: Where is the pain? Patient: Pain pain everywhere! ❔How do we approach a patient with multiple joint pains❔ (1/12) #polyarthritis #MedTwitter #MedEd #RheumTwitter

Excited to share my latest research! "Efficacy and safety of 10 mg versus 30 mg of oral prednisolone for acute CPP crystal arthritis: findings of a randomized controlled trial" 🔍 Check it out here: rdcu.be/dXfms #Rheumatology #CPPD #Research #arthritis #Prednisolone

Missing the in-person experience of the ACR conference, but grateful for the on-demand courses—an incredible wealth of information and insights to catch up on at my own pace. Learning never stops! #ACR2024 #ACR24

SGLT2 inhibitors don’t just lower glucose — they lower gout risk too 🧩🔥 As Lisa Stamp highlighted at #APLAR2025. #Gout #SGLT2i #Rheumatology

At #APLAR25, Prof. Sami Salman shared that long-term allopurinol protects against first-ever ACS in gout, while initiators face higher ACS risk. Colchicine stands out as CV protective, while NSAIDs & steroids may raise CV risk. #Gout #CardioRheum

Great talk by Prof. Dinesh Khanna on CTD-PAH 🫀 at #APLAR25. Focus: how anti-remodeling drugs are changing the treatment landscape. #PAH ✅ Activin/TGF-β crucial in PAH biology ✅ Upfront double/triple therapy improves outcomes ✅ Sotatercept improves morbidity & mortality

Great talk by Dr. Andrea Low on CTD-ILD 💡 She highlighted a personalized approach to treatment — balancing ILD extent, risk of progression, biology, extrapulmonary features & adverse effects. #APLAR25 #Rheumatology #ILD

Prof. Masataka Kuwana 🇯🇵 highlights: PH with ILD in SARDs = severe complication with high morbidity & mortality 🚨. 🌸 Inhaled treprostinil offers hope for better outcomes 💊 Sildenafil safe, well-tolerated, option if treprostinil unavailable #APLAR25 #Rheumatology #PH #ILD